Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of GGACT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 196.06 | 245 / 245 | 100% | 6.60 | 500 / 502 |
thymus | 100% | 177.18 | 651 / 653 | 99% | 4.12 | 600 / 605 |
intestine | 99% | 197.67 | 961 / 966 | 99% | 6.41 | 522 / 527 |
liver | 100% | 408.39 | 226 / 226 | 99% | 6.98 | 400 / 406 |
pancreas | 100% | 355.69 | 328 / 328 | 98% | 4.46 | 175 / 178 |
breast | 100% | 210.55 | 459 / 459 | 98% | 4.21 | 1092 / 1118 |
esophagus | 99% | 141.41 | 1433 / 1445 | 98% | 4.33 | 180 / 183 |
bladder | 100% | 166.71 | 21 / 21 | 97% | 4.91 | 489 / 504 |
stomach | 100% | 195.78 | 358 / 359 | 97% | 5.83 | 278 / 286 |
skin | 100% | 303.76 | 1806 / 1809 | 96% | 4.15 | 452 / 472 |
uterus | 98% | 137.14 | 167 / 170 | 97% | 3.78 | 446 / 459 |
ovary | 97% | 148.21 | 175 / 180 | 98% | 3.86 | 422 / 430 |
kidney | 100% | 1168.89 | 89 / 89 | 95% | 5.47 | 852 / 901 |
lung | 92% | 140.28 | 532 / 578 | 99% | 4.08 | 1140 / 1155 |
adrenal gland | 100% | 426.11 | 258 / 258 | 84% | 2.71 | 193 / 230 |
brain | 99% | 140.88 | 2613 / 2642 | 73% | 2.44 | 518 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.33 | 29 / 29 |
spleen | 100% | 208.59 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 205.07 | 1202 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 3.86 | 44 / 45 |
blood vessel | 98% | 120.66 | 1302 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 5.14 | 78 / 80 |
heart | 87% | 68.89 | 745 / 861 | 0% | 0 | 0 / 0 |
muscle | 86% | 72.77 | 691 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 140.54 | 771 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042219 | Biological process | cellular modified amino acid catabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0061929 | Molecular function | gamma-glutamylaminecyclotransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GGACT |
Protein name | Gamma-glutamylaminecyclotransferase (GGACT) (EC 4.3.2.8) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase) Gamma-glutamylamine cyclotransferase |
Synonyms | A2LD1 |
Description | FUNCTION: Contributes to degradation of proteins cross-linked by transglutaminases by degrading the cross-link between a lysine and a glutamic acid residue. Catalyzes the formation of 5-oxo-L-proline from L-gamma-glutamyl-L-epsilon-lysine. Inactive with L-gamma-glutamyl-alpha-amino acid substrates such as L-gamma-glutamyl-L-alpha-cysteine and L-gamma-glutamyl-L-alpha-alanine. . |
Accessions | ENST00000376250.6 ENST00000464500.5 ENST00000455100.2 ENST00000467518.5 ENST00000471912.1 ENST00000683975.1 M0R0M3 ENST00000492399.5 Q9BVM4 M0R217 |